@inproceedings{inproceedings, title  = {{Laboratory parameters in adolescent patients aged 12-17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to Week 52: results from the phase 3 ECZTRA 6 trial}},

 url = {{}},

 year = {{2025}},

 month = {{3}},

 author = {{Paller A and Cork M and Hong C-H and Soong W and Schneider S and Lo H and Pedersen LRM and Vacko E and Wollenberg A}},

 volume = {{145}},

 journal = {{JOURNAL OF INVESTIGATIVE DERMATOLOGY}},

 issue = {{3}},

 pages = {{e27-e27}},

 note = {{Accessed on 2025/10/26}}}